Clinical Trials Sponsored by Immunex Corporation
Total 6817 results
-
AmgenImmunex CorporationTerminatedJuvenile Rheumatoid Arthritis
-
AmgenImmunex CorporationCompleted
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
AmgenImmunex CorporationCompletedRheumatoid Arthritis
-
AmgenImmunex CorporationCompletedPsoriasis | Psoriatic Arthritis
-
AmgenImmunex CorporationCompleted
-
AbgenixImmunex CorporationCompletedProstate CancerUnited States
-
AmgenImmunex CorporationCompleted
-
AmgenImmunex CorporationCompleted
-
Massachusetts General HospitalImmunex CorporationTerminatedPsoriasisUnited States
-
University of Wisconsin, MadisonImmunex CorporationCompletedHIV InfectionsUnited States
-
Rockefeller UniversityImmune Design; IDRI CorporationCompleted
-
Ohio State University Comprehensive Cancer CenterImmunex CorporationCompletedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
Ohio State University Comprehensive Cancer CenterImmunex CorporationCompleted
-
Bionor Immuno ASCelgene CorporationCompleted
-
Bionor Immuno ASCelgene CorporationCompleted
-
National Institute of Allergy and Infectious Diseases...Immunex CorporationCompleted
-
Northwestern UniversityRegeneron Pharmaceuticals; Immunex Corporation; Pediatric Dermatology Research...CompletedChronic Pediatric Skin ConditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Immunex CorporationWithdrawnAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
AmgenWyeth is now a wholly owned subsidiary of Pfizer; Immunex CorporationCompleted
-
AmgenWyeth is now a wholly owned subsidiary of Pfizer; Immunex CorporationCompletedRheumatoid Arthritis
-
AmgenWyeth is now a wholly owned subsidiary of Pfizer; Immunex CorporationCompletedRheumatoid Arthritis
-
Immune DesignTerminatedMelanoma | Sarcoma | Ovarian Cancer | Non-small Cell Lung CancerUnited States
-
Immune PharmaceuticalsUnknownUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateIsrael
-
Immune ControlUnknownMultiple MyelomaUnited States
-
The Immune Response CorporationCompleted
-
The Immune Response CorporationCompleted
-
The Immune Response CorporationCompleted
-
Immune DesignTerminatedSarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic SarcomaUnited States, Canada
-
Immune DesignCompletedMerkel Cell CarcinomaUnited States
-
Immune PharmaceuticalsCompletedPemphigoid, BullousUnited States, Israel
-
Immune DesignCompletedMelanoma | Sarcoma | Breast Cancer | Ovarian Cancer | Non-small Cell Lung CancerUnited States
-
GenMont Biotech IncorporationBiomedical Development CorporationCompletedProbiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)Taiwan
-
Smart Immune SASRecruitingHealthy VolunteersFrance
-
Immune Biosolutions IncCompletedCOVID-19South Africa, Ukraine
-
Repertoire Immune MedicinesTerminatedRPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and MelanomaMelanoma | Cervical Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Repertoire Immune MedicinesTerminatedMelanoma | Head and Neck Cancer | HPV-Related Malignancy | Melanoma (Skin) | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Lung Cancer, Nonsmall CellUnited States
-
Intervene Immune, Inc.RecruitingImmunosenescence | Epigenetic AgingUnited States
-
Immune-Onc TherapeuticsCompletedSolid Tumor, AdultUnited States
-
Immune Biosolutions IncCompleted
-
Smart Immune SASRecruiting
-
Smart Immune SASRecruitingHematological MalignanciesUnited States
-
Immune-Onc TherapeuticsCompletedAdvanced Solid TumorChina
-
Immune Biosolutions IncCompletedCOVID-19Ukraine, South Africa
-
National Institute of Allergy and Infectious Diseases...The Immune Response CorporationTerminatedHIV InfectionsUnited States
-
Immunic AGActive, not recruitingRelapsing-Remitting Multiple Sclerosis (RRMS)Poland, Bulgaria, Romania, Ukraine
-
NImmune BiopharmaTerminatedCrohn's DiseaseUnited States